Skip to main content
. 2022 Aug 13;4(12):1043–1052. doi: 10.1016/j.cjco.2022.08.006

Figure 4.

Figure 4

Schematic diagram of mechanisms mediating the protective effect of statins in doxorubicin-induced cardiomyopathy. cam KIId, calcium-calmodulin-dependent protein kinases; DDR, DNA damage response; PLN, phospholamban; PP1, protein phosphatase I; ROS, reactive oxygen species; RyR2, ryanodine receptor 2; Serca2, sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2.